您的位置: 首页 > 2018年9月 第49卷 第5期 > 文字全文
2023年7月 第38卷 第7期11
目录

鼻咽癌放疗后鼻窦炎临床特征及其影响因素的Logistic分析

Logistic analysis of clinical characteristics and influencing factors of sinusitis after radiotherapy for nasopharyngeal carcinoma

来源期刊: 广州医药 | 24-28 发布时间:2021-11-29 收稿时间:2025/11/13 17:18:18 阅读量:36
作者:
关键词:
鼻咽癌放疗鼻窦炎危险因素
Nasopharyngeal carcinomaRadiotherapySinusitisRisk factors
DOI:
10.3969/j.issn.1000-8535.2018.05.006
收稿时间:
2018-04-16 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 探讨鼻咽癌(NPC)放疗致鼻窦炎发生的临床特征、影响因素。方法 回顾性分析2014年1月—2017年6月期间,我院收治的228例NPC患者临床资料,根据患者是否进行放疗,将患者分为非放疗组(106例)和放疗组(122例)。对比分析两组鼻咽癌致鼻窦炎的临床特点,以单因素和多因素Logistic分析鼻咽癌患者放疗后发生鼻窦炎的影响因素。结果 放疗组患者鼻窦炎发生率为81.97%,高于非放疗组患者鼻窦炎发生率54.72%,差异有统计学意义(P<0.05)。放疗组鼻窦炎累及部位发生率从高到低,依次为后组筛窦、蝶窦、前组筛窦、窦口鼻道复合体、额窦以及上颌窦。放疗组患者鼻窦炎后组筛窦、蝶窦累及率高于非放疗组患者,差异具有统计学意义(P<0.05)。单因素分析结果显示,放疗后鼻窦炎的发生,与患者年龄是否>50岁,病程是否>2年,是否存在鼻腔侵犯,肿瘤分期,是否使用滴鼻剂及是否进行鼻咽冲洗有关,差异有统计学意义(P<0.05)。多因素Logistic回归分析结果显示,患者病程>2年,存在鼻腔侵犯以及T3+T4期肿瘤是NPC放疗后鼻窦炎发生的独立危险因素;使用滴鼻剂和鼻咽冲洗是NPC放疗后鼻窦炎发生的保护因素。结论 NPC放疗后具有较高的鼻窦炎发生率,并且主要累及后组筛窦和蝶窦,对于病程>2年、存在鼻腔侵犯以及T3+T4期肿瘤的患者,应积极采取措施预防鼻窦炎的发生,使用滴鼻剂和鼻咽冲洗是预防NPC放疗后鼻窦炎发生的有效措施。
Objective To investigate the clinical features and influencing factors of nasosinusitis caused by nasopharyngeal carcinoma (NPC) radiotherapy. Methods The clinical data of 228 NPC patients admitted to our hospital from January 2014 to June 2017 were retrospectively analyzed. According to whether the patients were treated with radiotherapy, the patients were divided into non-radiotherapy group (106 cases) and radiotherapy group (122 cases). The clinical characteristics of nasosinusitis were analyzed and compared. Univariate and multivariate logistic analysis was used to analyze the influencing factors of nasosinusitis after radiotherapy in patients with nasopharyngeal carcinoma. Results The incidence of sinusitis was 81.97% in the radiotherapy group, which was higher than that in the non-radiotherapy group (54.72%). The difference was statistical significance (P<0.05). The incidence of sinusitis involvement in the radiotherapy group was in the order of ethmoid sinus, sphenoid sinus, anterior ethmoid sinus, sinus ostium and nasal tract sinus complex, frontal sinus, and maxillary sinus. The incidences of ethmoid sinus and sphenoid sinus in the post-nasal sinusitis group were higher than that in the non-radiotherapy group (P<0.05). Univariate analysis showed that the occurrence of sinusitis after radiotherapy was related to whether the patient's age was > 50 years, whether the disease duration was >2 years, whether there was nasal invasion, tumor staging, whether nasal drops were used, and whether nasopharyngeal irrigation was performed. Multivariate logistic regression analysis showed that patients with a disease course of >2 years had nasal invasion and T3+T4 tumors were independent risk factors for sinusitis after NPC radiotherapy; use of nasal drops and nasopharyngeal washing were protective factors. Conclusion There is a higher incidence of sinusitis after radiotherapy of NPC, and mainly affects the ethmoid sinus and sphenoid sinus in the posterior group. Patients with a disease course of >2 years, with nasal invasion, and T3+T4 tumors should actively take measures to prevent the occurrence of sinusitis. The use of nose drops and nasopharyngeal washing is an effective measure to prevent the occurrence of sinusitis after NPC radiotherapy.
1、 陈紫红. 放射性鼻窦炎术后鼻腔冲洗的研究进展[J]. 当代护士: 学术版 (中旬刊), 2016 (9): 11-14. 陈紫红. 放射性鼻窦炎术后鼻腔冲洗的研究进展[J]. 当代护士: 学术版 (中旬刊), 2016 (9): 11-14.
2、 彭鹏. 鼻腔冲洗及内镜下鼻腔清理治疗鼻咽癌放疗后鼻窦炎的疗效观察[J]. 中国现代医药杂志, 2014, 16(4): 69-70. 彭鹏. 鼻腔冲洗及内镜下鼻腔清理治疗鼻咽癌放疗后鼻窦炎的疗效观察[J]. 中国现代医药杂志, 2014, 16(4): 69-70.
3、 唐忠敏. 鼻咽癌放疗后继发放射性鼻窦炎进行鼻腔冲洗的进展[J]. 中国癌症防治杂志, 2013, 5(3): 287-289. 唐忠敏. 鼻咽癌放疗后继发放射性鼻窦炎进行鼻腔冲洗的进展[J]. 中国癌症防治杂志, 2013, 5(3): 287-289.
4、 LIM M,LEW-GOR S,DARBY Y,et al. The relationship between sub-jective assessment instruments in chronic rhinosinusitis[J]. Rhinology,2007,45(2): 144-147. LIM M,LEW-GOR S,DARBY Y,et al. The relationship between sub-jective assessment instruments in chronic rhinosinusitis[J]. Rhinology,2007,45(2): 144-147.
5、 苏艳霞, 李需, 郝俊芳, 等. 鼻咽癌调强放疗后鼻窦炎的临床观察及影响因素分析[J]. 中华放射肿瘤学杂志, 2013, 22(6): 469-472. 苏艳霞, 李需, 郝俊芳, 等. 鼻咽癌调强放疗后鼻窦炎的临床观察及影响因素分析[J]. 中华放射肿瘤学杂志, 2013, 22(6): 469-472.
6、 毛艳, 刘文其, 范小玲, 等. 鼻咽癌调强放疗与常规放疗后放射性鼻窦炎发生率的对比研究[J]. 肿瘤防治研究, 2012, 39(6): 735-738. 毛艳, 刘文其, 范小玲, 等. 鼻咽癌调强放疗与常规放疗后放射性鼻窦炎发生率的对比研究[J]. 肿瘤防治研究, 2012, 39(6): 735-738.
7、 黄若葵, 熊奇斌, 黄建晖, 等. 鼻咽癌放疗致鼻窦炎的影响因素分析及鼻内镜手术处理疗效观察[J]. 中国耳鼻咽喉颅底外科杂志, 2014, 20: 526-528. 黄若葵, 熊奇斌, 黄建晖, 等. 鼻咽癌放疗致鼻窦炎的影响因素分析及鼻内镜手术处理疗效观察[J]. 中国耳鼻咽喉颅底外科杂志, 2014, 20: 526-528.
8、 FENG S, FAN Y, LIANG Z, et al. Effect of intranasal steroids on rhinosinusitis after radiotherapy for nasopharyngeal carcinoma: clinical study[J]. J Laryngol Otol, 2016, 130(3): 265-271. FENG S, FAN Y, LIANG Z, et al. Effect of intranasal steroids on rhinosinusitis after radiotherapy for nasopharyngeal carcinoma: clinical study[J]. J Laryngol Otol, 2016, 130(3): 265-271.
9、 AYOUB N, WALGAMA E, THAMBOO A, et al. Efficacy of endoscopic sinus surgery for chronic rhinosinusitis following primary radiotherapy and concurrent chemotherapy for nasopharyngeal carcinoma[C]. Int Forum Allergy Rhinol 2017, 7(11): 1045-1051. AYOUB N, WALGAMA E, THAMBOO A, et al. Efficacy of endoscopic sinus surgery for chronic rhinosinusitis following primary radiotherapy and concurrent chemotherapy for nasopharyngeal carcinoma[C]. Int Forum Allergy Rhinol 2017, 7(11): 1045-1051.
10、 唐隽, 施思斯, 于青青, 等. 鼻咽癌放疗后继发慢性鼻窦炎的临床特征[J]. 山东大学耳鼻喉眼学报, 2015, 29(2): 52-54. 唐隽, 施思斯, 于青青, 等. 鼻咽癌放疗后继发慢性鼻窦炎的临床特征[J]. 山东大学耳鼻喉眼学报, 2015, 29(2): 52-54.
11、 苏群, 高力英, 李益民, 等. 鼻咽癌放疗后放射性鼻窦炎的影响因素及治疗效果探讨[J]. 实用肿瘤杂志, 2014, 29(3): 219-222. 苏群, 高力英, 李益民, 等. 鼻咽癌放疗后放射性鼻窦炎的影响因素及治疗效果探讨[J]. 实用肿瘤杂志, 2014, 29(3): 219-222.
12、 金加欣, 殷敏, 程雷. 慢性鼻-鼻窦炎诊断和治疗指南(2012年,昆明)解读[J]. 中国中西医结合耳鼻咽喉科杂志, 2013, 21(5): 388-391. 金加欣, 殷敏, 程雷. 慢性鼻-鼻窦炎诊断和治疗指南(2012年,昆明)解读[J]. 中国中西医结合耳鼻咽喉科杂志, 2013, 21(5): 388-391.
13、 FENG S, FAN Y, LIANG Z, et al. Effect of intranasal steroids on rhinosinusitis after radiotherapy for nasopharyngeal carcinoma: clinical study[J]. J Laryngol Otol, 2016, 130(3): 265-271. FENG S, FAN Y, LIANG Z, et al. Effect of intranasal steroids on rhinosinusitis after radiotherapy for nasopharyngeal carcinoma: clinical study[J]. J Laryngol Otol, 2016, 130(3): 265-271.
14、 HSIN C H, TSENG H C, LIN H P, et al. Sinus mucosa status in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: A 5-year follow-up[J]. Head Neck, 2016, 38(1): 29-35. HSIN C H, TSENG H C, LIN H P, et al. Sinus mucosa status in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: A 5-year follow-up[J]. Head Neck, 2016, 38(1): 29-35.
15、 WEI K R, ZHENG R S, ZHANG S W, et al. Nasopharyngeal carcinoma incidence and mortality in China in 2010[J]. Chin J Cancer, 2014, 33(8): 381. WEI K R, ZHENG R S, ZHANG S W, et al. Nasopharyngeal carcinoma incidence and mortality in China in 2010[J]. Chin J Cancer, 2014, 33(8): 381.
16、 CHUA M L K, WEE J T S, HUI E P, et al. Nasopharyngeal carcinoma[J]. Lancet, 2016, 387(10022): 1012-1024. CHUA M L K, WEE J T S, HUI E P, et al. Nasopharyngeal carcinoma[J]. Lancet, 2016, 387(10022): 1012-1024.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录